Status:
TERMINATED
Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Collaborating Sponsors:
Lungenfibrose e.V.
Conditions:
Idiopathic Pulmonary Fibrosis and COPD
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
As the result of our last study "Long Term effects of an Inpatient Pulmonary Program in Patients with Pulmonary Fibrosis" already demonstrated the positive effects of a Pulmonary Rehabiliation on the ...
Eligibility Criteria
Inclusion
- COPD GOLD III-IV
- IPF according Pulmonary Guidelines
Exclusion
- \< 30% FVC comorbidities with a negativ influence on the prognosis neurological and orthopaedic deficits, which make the participation of the pulmonary rehabilitation impossible non-compliance no written informed consent of the patient
Key Trial Info
Start Date :
February 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03477526
Start Date
February 26 2019
End Date
February 27 2019
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schön Klinik Berchtesgadener Land
Schönau am Königssee, Germany, 83471